| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/15/2004 | WO2002070747A9 Method of molecular diagnosis of chronic myelogenous leukemia |
| 01/15/2004 | WO2002042777A3 Modulation of the interaction between evh1 domains |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010218 Injecting an aberrant tissue-selective photosensitizer into the bloodstream, exposing the aberrant tissue to light to activate the photosensitizer which increases the permeablitiy of the vasculature; injecting a chemotherapeutic agent |
| 01/15/2004 | US20040010148 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders |
| 01/15/2004 | US20040010141 Antiinflammatory agents; anticancer agents; rheumatic disorders; cardiovascular disorders |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010118 Novel proteins and nucleic acids encoding same |
| 01/15/2004 | US20040010029 Also benzothiophene derivatives; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and infections; modulating T helper cells, Th1/ Th2, and inhibiting the transcription of IL-4 |
| 01/15/2004 | US20040010027 Tumor angiogenesis and metastasis inhibition. |
| 01/15/2004 | US20040010023 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 01/15/2004 | US20040010020 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 01/15/2004 | US20040010019 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 01/15/2004 | US20040010013 Cannabinoid receptor ligands |
| 01/15/2004 | US20040010011 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/15/2004 | US20040010010 Melanocortin receptor ligands |
| 01/15/2004 | US20040010007 Also thio, sulfoxy and sulfonyl derivatives; imidazotetrazolopyrimidines and intermediates |
| 01/15/2004 | US20040010002 Also identifying agents that are useful for alleviating and inhibiting lymphoproliferative disorders or inhibiting metastasis of lymphatic tumors |
| 01/15/2004 | US20040010001 Methods and compositions for modulating cell proliferation and cell death |
| 01/15/2004 | US20040009996 4-(1,2- or 2,1-benzoxazol-5-yl)-2-aminopyrimidines |
| 01/15/2004 | US20040009994 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 01/15/2004 | US20040009983 Azaindoles |
| 01/15/2004 | US20040009981 Oxazole, thiazole, 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives of pyrimidines, 1,2,4- and 1,3,5-triazines |
| 01/15/2004 | US20040009980 Calcilytic compounds |
| 01/15/2004 | US20040009974 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles |
| 01/15/2004 | US20040009968 Indazole compounds useful as protein kinase inhibitors |
| 01/15/2004 | US20040009967 May contain further anticancer or immunosuppressive agents |
| 01/15/2004 | US20040009965 Treating hyperproliferative disorders |
| 01/15/2004 | US20040009962 Combined estrogen blockade of the breast with exemestane and raloxifene |
| 01/15/2004 | US20040009959 Thioether sulphamate steroids as steroid inhibtors and anti-cancer compounds |
| 01/15/2004 | US20040009958 Inhibiting hyperproliferation of malignant or neoplastic cells in acute lymphobalstic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia and plasma cell dyscrasias. |
| 01/15/2004 | US20040009948 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 01/15/2004 | US20040009941 Microspheres and adjuvants for DNA vaccine delivery |
| 01/15/2004 | US20040009939 Methods of enhancing immune induction involving MDA-7 |
| 01/15/2004 | US20040009928 Isolation from a new marine microbe, strain PO13-046, belonging to the genus Actinomadura sp. |
| 01/15/2004 | US20040009914 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 01/15/2004 | US20040009913 Detecting, identifying and screening for srf signal transduction pathway elements for diagnosis |
| 01/15/2004 | US20040009897 Stabilized synthetic immunogen delivery system |
| 01/15/2004 | US20040009895 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 01/15/2004 | US20040009604 Plasmid which codes envelop fusogenic membrane protein for treating cell proliferative disorders; antitumor agents; immunotherapy; gene therapy |
| 01/15/2004 | US20040009594 Propagating cytotoxic t lymphocytes from hemopoietic stem cells and using them for treating cancer; immunotherapy |
| 01/15/2004 | US20040009588 Comprises targeted adenoviral expression vector coding antitumor agent; gene therapy; gene expression inhibition |
| 01/15/2004 | US20040009551 Comprises nucleotide sequences coding peptide antibiotic for treatment of parasitic infection and cell proliferative disorders |
| 01/15/2004 | US20040009546 Compositions and methods for inhibiting microbial adhesion |
| 01/15/2004 | US20040009475 Tumor cells to cytotoxic chemotherapeutic agents, especially antimetabolites and agents that damage DNA; excision repair cross-complementing (ERCC1) gene; thymidylate synthase (TS) |
| 01/15/2004 | US20040009248 Method for improving the cell protection |
| 01/15/2004 | US20040009244 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 01/15/2004 | US20040009240 For treatment of squamous cell carcinomas, tumours and other metastatic states (lung cancer) |
| 01/15/2004 | US20040009239 Use of anoectochilus formosanus plant extracts and their derived fractions as herbal medicines or nutraceutical supplements for chemoprevention or treatment of human malignancies |
| 01/15/2004 | US20040009233 Shark meat extract |
| 01/15/2004 | US20040009232 Dispersion of a liposoluble substance in water in the presence of a surfactant, adding a water soluble polyhydroxylated solid excipient such as mannitol, and granulating; drug delivery of megestrol acetate; excellent water dispersibility |
| 01/15/2004 | US20040009217 Therapeutic liposome composition and method |
| 01/15/2004 | US20040009216 Administering liposomes comprising phospholipids and an aqueous layer, said liposomes having specified average diameter; treating various cardiovascular disorders, reducing cholesterol |
| 01/15/2004 | US20040009212 .2-.5% of a mucoadhesive polymer of carboxylvinylpolyester (i.e. carbopol or carbomer) and celluloses, 15%-40% of a thermoresponsive polymer having two critical points and a balance of water |
| 01/15/2004 | US20040009195 Modified sialic acid vaccines |
| 01/15/2004 | US20040009189 Antimutagenic effects of ganoderma lucidum spores |
| 01/15/2004 | US20040009185 Enhancing the immune response to an antigen by presensitzing with an inducing agent prior to immunizing with the agent and the antigen |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | DE10229070A1 Phenylderivate 5 Phenyl derivatives 5 |
| 01/15/2004 | DE10228049A1 Flüssige Zubereitung enthaltend Oligopeptide The liquid formulation containing oligopeptides |
| 01/15/2004 | DE10204271B4 Verfahren zur Gewinnung von Betulinsäure-Monoethanolat A method for obtaining betulinic acid-Monoethanolat |
| 01/15/2004 | CA2767092A1 Novel compounds, pharmaceutical compositions containing same and methods of use for same |
| 01/15/2004 | CA2494508A1 Nucleic acid compositions for stimulating immune responses |
| 01/15/2004 | CA2492278A1 Pharmaceutical composition containing chlorogenic acid analogs for the treatment of chronic myeloid leukaemia |
| 01/15/2004 | CA2492010A1 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | CA2491947A1 The use of specified tcf target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which tcf/.beta.-catenin/wnt signalling plays a central role |
| 01/15/2004 | CA2491907A1 Oncolytic virus replicating selectively in tumor cells |
| 01/15/2004 | CA2491669A1 Neoplasm specific antibodies and uses thereof |
| 01/15/2004 | CA2491640A1 Ruthenium anticancer complexes |
| 01/15/2004 | CA2491614A1 Compounds and methods for treating cancer and inflammation |
| 01/15/2004 | CA2491484A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 01/15/2004 | CA2491455A1 Novel use of imidazotriazinones |
| 01/15/2004 | CA2491132A1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors |
| 01/15/2004 | CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | CA2490708A1 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 01/15/2004 | CA2490494A1 Pkc activation as a means for enhancing sapp.alpha. secretion and improving cognition using bryostatin type compounds |
| 01/15/2004 | CA2490097A1 Di-aryl-substituted-ethane pyridone pde4 inhibitors |
| 01/15/2004 | CA2489860A1 Use of an antibody against s100a8 or s100a9 as chemotactic factor inhibitor for modulating inflammatory reactions |
| 01/15/2004 | CA2489562A1 Mitotic kinesin binding site |
| 01/15/2004 | CA2489396A1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 01/15/2004 | CA2489166A1 Substituted anthranilic amide derivatives and methods of use |
| 01/15/2004 | CA2488885A1 Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures |
| 01/15/2004 | CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 01/15/2004 | CA2488736A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 01/15/2004 | CA2460051A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives |
| 01/14/2004 | EP1380650A1 Conditionally replicating viral vectors and their use |
| 01/14/2004 | EP1380644A1 The use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role |
| 01/14/2004 | EP1380594A1 Fibroblast growth factor-10 |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1380587A2 Oxazolo, thiazolo and selenazolo (4,5-c)-quinoline-4-amines and analogs thereof |
| 01/14/2004 | EP1380586A2 Photoactive benzoporphyrin derivatives |
| 01/14/2004 | EP1380581A1 Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 01/14/2004 | EP1380579A1 Novel physiologically active substances |
| 01/14/2004 | EP1380574A1 9-aminoacridine derivates and process for the preparation thereof |
| 01/14/2004 | EP1380571A1 Compounds useful for treating allergic and inflammatory diseases |
| 01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
| 01/14/2004 | EP1380305A1 Photodynamic therapy for the enhancement of vascular permeability |
| 01/14/2004 | EP1380303A1 Combination therapy to treat hepatitis B virus |